These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35150566)

  • 1. Flexible TALEs for an expanded use in gene activation, virulence and scaffold engineering.
    Becker S; Mücke S; Grau J; Boch J
    Nucleic Acids Res; 2022 Feb; 50(4):2387-2400. PubMed ID: 35150566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Transcription Activator-Like Effectors in Xanthomonas oryzae.
    Erkes A; Reschke M; Boch J; Grau J
    Genome Biol Evol; 2017 Jun; 9(6):1599-1615. PubMed ID: 28637323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TAL effector repeat architecture for frameshift binding.
    Richter A; Streubel J; Blücher C; Szurek B; Reschke M; Grau J; Boch J
    Nat Commun; 2014 Mar; 5():3447. PubMed ID: 24614980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered TALE Repeats for Enhanced Imaging-Based Analysis of Cellular 5-Methylcytosine.
    Muñoz-López Á; Jung A; Buchmuller B; Wolffgramm J; Maurer S; Witte A; Summerer D
    Chembiochem; 2021 Feb; 22(4):645-651. PubMed ID: 32991020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective recognition of
    Rathi P; Maurer S; Summerer D
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrediTALE: A novel model learned from quantitative data allows for new perspectives on TALE targeting.
    Erkes A; Mücke S; Reschke M; Boch J; Grau J
    PLoS Comput Biol; 2019 Jul; 15(7):e1007206. PubMed ID: 31295249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering DNA Backbone Interactions Results in TALE Scaffolds with Enhanced 5-Methylcytosine Selectivity.
    Rathi P; Witte A; Summerer D
    Sci Rep; 2017 Nov; 7(1):15067. PubMed ID: 29118409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Broad-Spectrum Bacterial Blight Resistance by Simultaneously Disrupting Variable TALE-Binding Elements of Multiple Susceptibility Genes in Rice.
    Xu Z; Xu X; Gong Q; Li Z; Li Y; Wang S; Yang Y; Ma W; Liu L; Zhu B; Zou L; Chen G
    Mol Plant; 2019 Nov; 12(11):1434-1446. PubMed ID: 31493565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TALE: a tale of genome editing.
    Zhang M; Wang F; Li S; Wang Y; Bai Y; Xu X
    Prog Biophys Mol Biol; 2014 Jan; 114(1):25-32. PubMed ID: 24291598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broken TALEs: Transcription Activator-like Effectors Populate Partly Folded States.
    Geiger-Schuller K; Barrick D
    Biophys J; 2016 Dec; 111(11):2395-2403. PubMed ID: 27926841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N6-Position of Adenine Is a Blind Spot for TAL-Effectors That Enables Effective Binding of Methylated and Fluorophore-Labeled DNA.
    Flade S; Jasper J; Gieß M; Juhasz M; Dankers A; Kubik G; Koch O; Weinhold E; Summerer D
    ACS Chem Biol; 2017 Jul; 12(7):1719-1725. PubMed ID: 28493677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmable DNA-binding proteins from Burkholderia provide a fresh perspective on the TALE-like repeat domain.
    de Lange O; Wolf C; Dietze J; Elsaesser J; Morbitzer R; Lahaye T
    Nucleic Acids Res; 2014 Jun; 42(11):7436-49. PubMed ID: 24792163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Application of DNA Modification-Specific Transcription-Activator-Like Effectors.
    Buchmuller B; Muñoz-López Á; Gieß M; Summerer D
    Methods Mol Biol; 2021; 2198():381-399. PubMed ID: 32822046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimerization Enables Gene Synthesis and Lentiviral Delivery of Customizable TALE-Based Effectors.
    Fang Y; Stroukov W; Cathomen T; Mussolino C
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The last half-repeat of transcription activator-like effector (TALE) is dispensable and thereby TALE-based technology can be simplified.
    Zheng CK; Wang CL; Zhang XP; Wang FJ; Qin TF; Zhao KJ
    Mol Plant Pathol; 2014 Sep; 15(7):690-7. PubMed ID: 24521457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An engineered promoter driving expression of a microbial avirulence gene confers recognition of TAL effectors and reduces growth of diverse Xanthomonas strains in citrus.
    Shantharaj D; Römer P; Figueiredo JFL; Minsavage GV; Krönauer C; Stall RE; Moore GA; Fisher LC; Hu Y; Horvath DM; Lahaye T; Jones JB
    Mol Plant Pathol; 2017 Sep; 18(7):976-989. PubMed ID: 27362693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting the sequence diversity of TALE-like repeats to vary the strength of dTALE-promoter interactions.
    de Lange O; Schandry N; Wunderlich M; Berendzen KW; Lahaye T
    Synth Biol (Oxf); 2017 Jan; 2(1):ysx004. PubMed ID: 32995505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of increasing numbers of repeats on TAL effector DNA binding specificity.
    Rinaldi FC; Doyle LA; Stoddard BL; Bogdanove AJ
    Nucleic Acids Res; 2017 Jun; 45(11):6960-6970. PubMed ID: 28460076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Role of the Last Half Repeat in TAL Effectors Revealed by a Molecular Simulation Study.
    Wan H; Chang S; Hu JP; Tian XH; Wang MH
    Biomed Res Int; 2016; 2016():8036450. PubMed ID: 27803930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of adaptation of TAL effectors on host susceptibility to Xanthomonas.
    Teper D; Wang N
    PLoS Genet; 2021 Jan; 17(1):e1009310. PubMed ID: 33465093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.